Stock 6922 CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cryofocus Medtech (Shanghai) Co., Ltd.

Equities

6922

CNE100005MV5

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:12 2024-06-14 am EDT 		5-day change 1st Jan Change
7.26 HKD +6.61% Intraday chart for Cryofocus Medtech (Shanghai) Co., Ltd. +5.37% -61.42%
Mar. 27 Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 15 Cryofocus Medtech Gets Marketing Approval in China for Cryoadhesion System MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • The company appears highly valued given the size of its balance sheet.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD. Stock Cryofocus Medtech (Shanghai) Co., Ltd.
-61.42% 208M -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 795B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 627B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
B-
ABBVIE INC. Stock AbbVie Inc.
+8.79% 294B
C+
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 245B
B+
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 222B
A+
NOVARTIS AG Stock Novartis AG
+11.95% 215B
B-
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 6922 Stock
  4. Ratings Cryofocus Medtech (Shanghai) Co., Ltd.